Careers

Learn more

Qualified professionals

Learn more

Trainee & intern programmes

Learn more

Offices

New York

Learn more

San Francisco

Learn more
A&L Goodbody logo

Legal Updates & Insights

  • article

    Looking Ahead: preparing for pay transparency

    In this article, we explore what companies should be aware of ahead of the implementation of the EU Pay Transparency Directive in Ireland. 

    Employment
  • article

    What’s on the sustainability agenda for 2026?

    The EU’s simplification agenda brings short-term uncertainty across a broad range of topics. This article focuses on sustainability and the matters that businesses should be thinking about as 2026 approaches.

    Asset Management & Investment Funds
  • article

    That’s a wrap - ESG research report series

    In this article, we look back on the ESG research report and the key topics explored in the four-part series of articles and podcasts.

    ESG & Sustainability
  • article

    The interaction between environmental and financial crime – What do businesses need to know?   

    In this article, we examine the types of activities that are considered environmental crimes; their recognition as predicate offences to money laundering and how environmental harm is being criminalised.

    ESG & Sustainability
  • article

    Public consultation on National Life Sciences Strategy launched

    The Department of Enterprise Trade and Employment has launched a public consultation on a new National Life Sciences Strategy designed to ensure Ireland’s life sciences sector remains globally competitive.

    Life Sciences
  • article

    Amazon v Commission: EU’s General Court dismisses Amazon’s challenge to VLOP designation

    The General Court of the European Union recently delivered a significant judgment, dismissing Amazon’s challenge to the European Commission decision to designate Amazon Store as a “very large online platform” (VLOP) under the Regulation (EU) 2022/2065 (the Digital Services Act or DSA).

    Technology
  • article

    Financial Services Regulation and Compliance - Cross Sectoral and Other October 2025

    At European level, the EBA published report on tackling ML/TF risks posed by CASPs and issuers of ARTs and EMTs, GDPR statement regarding DORA oversight, ESMA issues new Q&A on MiCAR and revised guidelines on outsourcing to cloud service providers.

    Financial Regulation Advisory
  • article

    Financial Services Regulation and Compliance - Investment Firms October 2025

    At European level, ESMA announces upcoming publication of standard market size for equity and equity-like financial instruments, clarifies application of the revised MiFID II/MiFIR rules and together with the EBA, recommends revisions to IFD/IFR.

    Asset Management & Investment Funds
  • article

    Financial Services Regulation and Compliance - Insurance October 2025

    Domestically, the CBI announced change to Insurance Compensation Fund and published annual Private Motor Report. At European level, EIOPA launched new set of consultations related to the Solvency II Review.

    Finance
  • article

    Financial Services Regulation and Compliance - Funds October 2025

    Domestically, the CBI published its report on ESMA’s CSA on sustainability risks and disclosures in the investment funds sector. At European level, ESMA published draft RTS on open-ended loan-originating alternative investment funds under AIFMD II.

    Asset Management & Investment Funds
  • article

    Financial Services Regulation and Compliance - Banking and Payments October 2025

    At European level, the EBA reports on AML/CFT supervision of EU banks, reports on white labelling and supervisory convergence, ECB calls for stronger regulation of non-banks and SRB launches consultation on communication guidance for banks.

    Finance
  • article

    Clinical trials in Ireland under the EU CTR – Five key questions answered

    In this article we address five important questions that sponsors should consider before they conduct a clinical trial in Ireland under the new regime.

    Life Sciences